NCT06008288 A Phase II Study Evaluating JAB-21822 Monotherapy in Adult Patients With Pancreatic Cancer and Other Solid Tumors Harboring the KRAS p.G12C Mutation. Status RECRUITING Phase PHASE2
NCT06005974 A Study of REC-4881 in Participants With Cancers Which Have an AXIN1 or APC Mutation Status TERMINATED Phase PHASE2
NCT05991349 A Study of IBI129 in Subjects With Unresectable, Locally Advanced or Metastatic Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05990920 Study of Allogeneic Blood-derived Natural Killer Cells to Evaluate Safety and Tolerability in Cancer Refractory to Conventional Therapy Status COMPLETED Phase PHASE1
NCT05989724 A First-in-Human Study of SON-DP in Participants With Relapsed/Refractory Intolerant to Standard of Care Therapies for Advanced/Metastatic Solid Tumors Status RECRUITING Phase PHASE1
NCT05985161 A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors Status RECRUITING Phase PHASE2
NCT05982522 IN10018 Combination Therapy in Previously-treated Solid Tumors Status WITHDRAWN Phase PHASE1/PHASE2
NCT05981703 A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors Status RECRUITING Phase PHASE1
NCT05971589 A Clinical Study on LM103 Injection for the Treatment of Advanced Solid Tumors Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT05971576 A Clinical Study on TILs for the Treatment of Advanced Solid Tumors Status NOT_YET_RECRUITING Phase EARLY_PHASE1
NCT05965856 A Study of SI-B003 and BL-B01D1+SI-B003 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma and Other Solid Tumors Status RECRUITING Phase PHASE2
NCT05943041 Live Biotherapeutic Product GB104 Phase 1 Study in Colorectal Cancer Status COMPLETED Phase PHASE1
NCT05941936 A Clinical Study on LM103 for the Treatment of Advanced Solid Tumors Status RECRUITING Phase EARLY_PHASE1
NCT05940896 RC48-ADC Combined With Radiotherapy in the Treatment of Locally Advanced Solid Tumors With HER2 Expression Status RECRUITING Phase PHASE1
NCT05940181 A Safety and Efficacy Study of XH001 Combined With Sintilimab Injection in Advanced Solid Tumors Status RECRUITING Phase NA